Keynote Speeches |
Dr. S. Eswara Reddy
Drugs Controller General, CDSCO |
Latest trend of pharmaceutical and medical device regulation, and international cooperation of India |
|
Dr. Takao Yamori
Executive Director, PMDA |
Latest Trend of Pharmaceutical and Medical Device Regulation in Japan |
|
Stem Cells and Products/ Regenerative Medicine Products |
Mr. Kenji Kuroiwa
Deputy Director, Office of Regenerative Medicine Product Evaluation, MHLW |
Regulatory frameworks of regenerative medicines and products review in Japan |
|
Dr. V. G. Somani
Joint Drugs Controller (I), CDSCO |
Regulatory framework for Stem Cell and Products review in India |
|
Pharmaceuticals Part A. GMP/Quality |
Mr. Hiroshi Sakurai
GMP Inspector, Office of Manufacturing/Quality and Compliance, PMDA |
Experience of GMP inspections by PMDA
and general advices for manufactures |
|
Dr. K. Bangarurajan
Joint Drugs Controller (I), CDSCO |
Enhancement of GMP inspections in India |
|
Mr. Tomonori Nakagawa
Otsuka Pharmaceutical Co., Ltd., JPMA |
Development and utilization of Site Master File |
|
Mr. Ranga Chandrashekar
Deputy Drugs Controller (I), CDSCO |
Compliance with the GMP standard in the international level |
|
Pharmaceuticals Part B. Pharmacovigilance |
Dr. Daisaku Sato
Chief Management Officer, PMDA |
Postmarketing Regulations in Japan
and Real World Data Utilization
for Drug Safety Assessment |
|
Dr. V Kalaiselvan
Indian Pharmacopoeia Commission |
Pharmacovigilance Programme of India |
|
Ms. Ayami Komatsu
Torii Pharmaceutical Co.,LTD, JPMA |
Pharmacovigilance in Japan: Industry perspective |
|
Dr. Jamal Baig
Global Pharmacovigilance Country Leader,MSD Pharmaceutical Pvt. Ltd.,
India. |
Pharmacovigilance System in India: Industry Perspective |
|
Pharma clusters/hubs in India |
Maharashtra/ Telangana States |
Pharma clusters/hubs in India
A perspective |
|
Medical Devices |
Dr. V. G. Somani
Joint Drugs Controller (I)
Mr. Aseem Sahu
Deputy Drugs Controller (I) |
Update on the Implementation of Medical Device Rules in India |
|
Mr. Rajivnath
AIMED
Mr. Probir Das
Terumo |
Industry’s response and preparation to the medical device regulation in India |
|
Mr. Shinwa Shibata
Inspector, Office of Non-clinical and Clinical Compliance, PMDA |
GCP/Clinical Investigation in Japan |
|
Dr. Kazuaki Sekiguchi
Abbott, JFMDA |
GCP/Clinical Investigation in Japan: Industry perspective |
|
Mr. Kensei Tanaka
Inspector, Office of Safety I, PMDA |
Post market surveillance and vigilance in Japan |
|
Mr. Hideki Watanabe
Terumo, JFMDA |
Post market surveillance/vigilance in Japan: Industry perspective |
|